{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:19:34Z","timestamp":1741238374392,"version":"3.38.0"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"},{"start":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T00:00:00Z","timestamp":1739232000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/deed.de"}],"funder":[{"name":"Universit\u00e4tsklinikum RWTH Aachen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Innere Medizin"],"published-print":{"date-parts":[[2025,3]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title>\n          <jats:p>Impfungen stellen eine wichtige Pr\u00e4ventionsma\u00dfnahme gegen Viruserkrankungen dar und haben seit ihrer Einf\u00fchrung schon viele Menschenleben gerettet. Heutzutage kann jeder Arzt bzw. jede \u00c4rztin eine Impfung verabreichen. Bei Patienten mit chronischen Erkrankungen sollte eine Indikationsimpfung erfolgen. Generell bietet es sich an, wenn m\u00f6glich, eine Koadministration vorzunehmen, die in der Regel bei vielen Impfstoffen, insbesondere Totimpfstoffen, problemlos m\u00f6glich ist. Ein entsprechendes Qualit\u00e4tsmanagement vermag Komplikationen zu vermeiden. Wichtig ist es auch, die Patienten \u00fcber Impfungen zu informieren und sie ggf. nach der ersten Impfung an ihren Zweittermin zu erinnern, um die maximale Wirksamkeit zu gew\u00e4hrleisten.<\/jats:p>","DOI":"10.1007\/s00108-025-01857-w","type":"journal-article","created":{"date-parts":[[2025,2,11]],"date-time":"2025-02-11T16:45:46Z","timestamp":1739292346000},"page":"331-337","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Wege f\u00fcr bessere Impfraten","Ways to improve vaccination rates"],"prefix":"10.1007","volume":"66","author":[{"given":"J\u00fcrgen","family":"Floege","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toralf","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christoph","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Uwe","family":"Heemann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baptist","family":"Gallwitz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"Witzke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,11]]},"reference":[{"issue":"11","key":"1857_CR1","first-page":"A520","volume":"116","author":"C Betsch","year":"2019","unstructured":"Betsch\u00a0C, Hirschhausen\u00a0E, Zylka-Menhorn\u00a0V (2019) Professionelle Gespr\u00e4chsf\u00fchrung \u2013 wenn Reden Gold wert ist. Dtsch \u00c4rztebl 116(11):A520\u2013A527","journal-title":"Dtsch \u00c4rztebl"},{"key":"1857_CR2","doi-asserted-by":"crossref","unstructured":"Chandler R, Montenegro N, Llorach C et\u00a0al (2024) Immunogenicity, reactogenicity, and safety of AS01E-adjuvanted RSV prefusion F protein-based candidate vaccine (RSVpreF3 OA) when co-administered with a\u00a0seasonal quadrivalent influenza vaccine in older adults: results of a\u00a0phase\u00a03, open-label, randomized controlled trial. Clin Infect Dis: ciad786","DOI":"10.1093\/cid\/ciad786"},{"key":"1857_CR3","unstructured":"Deutsches \u00c4rzteblatt (2019) Viele Menschen haben keinen Impfpass. https:\/\/www.aerzteblatt.de\/nachrichten\/107409\/Viele-Menschen-haben-keinen-Impfpass. Zugegriffen: 23. Sept. 2024"},{"key":"1857_CR4","doi-asserted-by":"publisher","first-page":"7923","DOI":"10.1016\/j.vaccine.2018.06.076","volume":"36","author":"EM Dumit","year":"2018","unstructured":"Dumit\u00a0EM, Novillo-Ortiz\u00a0D, Contreras\u00a0M et\u00a0al (2018) The use of eHealth with immunizations: an overview of systematic reviews. Vaccine 36:7923\u20137928","journal-title":"Vaccine"},{"key":"1857_CR5","unstructured":"Haus\u00e4rztliche Vertragsgemeinschaft (2024) HZV \u2013 Wichtige \u00c4nderungen im TK-Vertrag zum 01.07.2024. https:\/\/www.haev.de\/fileadmin\/user_upload\/2024_05_14_Vertragsanpassung_TK_Bund_V4_ahe_ohne_Mergefelder__1_.pdf. Zugegriffen: 23. Sept. 2024"},{"key":"1857_CR6","volume-title":"Einstellungen, Wissen und Verhalten von Erwachsenen und Eltern gegen\u00fcber Impfungen \u2013 Ergebnisse der Repr\u00e4sentativbefragung 2022 zum Infektionsschutz: Impfungen im Erwachsenenalter (Teilbericht\u00a02). BZgA-Forschungsbericht","author":"N Horstk\u00f6tter","year":"2022","unstructured":"Horstk\u00f6tter\u00a0N, Seefeld\u00a0L, M\u00fcller\u00a0U et\u00a0al (2022) Einstellungen, Wissen und Verhalten von Erwachsenen und Eltern gegen\u00fcber Impfungen \u2013 Ergebnisse der Repr\u00e4sentativbefragung 2022 zum Infektionsschutz: Impfungen im Erwachsenenalter (Teilbericht\u00a02). BZgA-Forschungsbericht. Bundeszentrale f\u00fcr gesundheitliche Aufkl\u00e4rung, K\u00f6ln"},{"issue":"1","key":"1857_CR7","first-page":"CD003941","volume":"1","author":"JC Jacobson Vann","year":"2018","unstructured":"Jacobson Vann\u00a0JC, Jacobson\u00a0RM, Coyne-Beasley\u00a0T et\u00a0al (2018) Patient reminder and recall interventions to improve immunization rates. Cochrane Database Syst Rev 1(1):CD3941","journal-title":"Cochrane Database Syst Rev"},{"key":"1857_CR8","unstructured":"Kassen\u00e4rztliche Bundesvereinigung (2024) Anwendungen in der ePA. https:\/\/www.kbv.de\/html\/e-impfpass.php. Zugegriffen: 23. Sept. 2024"},{"key":"1857_CR9","unstructured":"Kassen\u00e4rztliche Bundesvereinigung (2024) PraxisCheck. Selbstbewertung Impfen. https:\/\/praxischeck.kbv.de\/mpc\/courses\/hinweise.xhtml?courseIdToStart=284689. Zugegriffen: 23. Sept. 2024"},{"key":"1857_CR10","unstructured":"Robert-Koch-Institut (2024) Beschluss zur Empfehlung der STIKO f\u00fcr eine Standard-impfung gegen Erkrankungen durch Respiratorische Synzytial-Viren (RSV) f\u00fcr Personen \u2265\u202f75\u00a0Jahre sowie zur Indikationsimpfung von Personen im Alter von 60\u00a0bis 74\u00a0Jahren mit Risikofaktoren. Epid Bull 32:"},{"key":"1857_CR11","first-page":"1","volume":"4","author":"Robert-Koch-Institut","year":"2024","unstructured":"Robert-Koch-Institut (2024) Empfehlungen der St\u00e4ndigen Impfkommission beim Robert Koch-Institut 2024. Epid Bull 4:1\u201372","journal-title":"Epid Bull"},{"key":"1857_CR12","first-page":"3","volume":"49","author":"Robert-Koch-Institut","year":"2022","unstructured":"Robert-Koch-Institut (2022) Impfquoten bei Erwachsenen in Deutschland. Epid Bull 49:3\u201327","journal-title":"Epid Bull"},{"key":"1857_CR13","unstructured":"Robert-Koch-Institut (2024) Kurz & Knapp: Faktenbl\u00e4tter zum Impfen.. Zugegriffen: 23. Sept. 2024"},{"key":"1857_CR14","unstructured":"Robert-Koch-Institut, YOUSE (2022) Verantwortlichkeiten, Kosten-Nutzen Abw\u00e4gungen und Digitalisierungsstress \u2013 Ergebnisse einer qualitativen Studie zur Relevanz von Recall-Systemen am Beispiel der HPV-Impfung. https:\/\/www.rki.de\/DE\/Content\/Infekt\/Impfen\/Forschungsprojekte\/abgeschlossene_Projekte\/HPV-Impfung-Recallsysteme\/Ergebnisse.html. Zugegriffen: 23. Sept. 2024"},{"key":"1857_CR15","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1007\/s00103-019-02912-2","volume":"62","author":"J Schelling","year":"2019","unstructured":"Schelling\u00a0J, Thorvaldsson\u00a0I, Sanftenberg\u00a0L (2019) Elektronische Impfmanagementsysteme in der Praxis zur Verbesserung der Impfquoten. Bundesgesundheitsbl 62:433\u2013439","journal-title":"Bundesgesundheitsbl"},{"key":"1857_CR16","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1007\/s44266-023-00060-0","volume":"99","author":"V Souhrada","year":"2023","unstructured":"Souhrada\u00a0V, Zrenner\u00a0M, Schaubroeck\u00a0E et\u00a0al (2023) Klinische Qualit\u00e4tssteuerung \u2013 ein praktischer Versuch in der Hausarztpraxis am Beispiel der Influenzaimpfung. Z\u00a0Allg Med 99:190\u2013195","journal-title":"Z Allg Med"},{"key":"1857_CR17","volume-title":"Steigerung von Impfraten durch elektronische Impfplaner \u2013 Teil\u00a0I. Impfquoten bei chronisch kranken Personen","author":"H Thiesemann-Reith","year":"2012","unstructured":"Thiesemann-Reith\u00a0H (2012) Steigerung von Impfraten durch elektronische Impfplaner \u2013 Teil\u00a0I. Impfquoten bei chronisch kranken Personen. InMed, Berlin (In: Impfbrief.de)"},{"issue":"8","key":"1857_CR18","doi-asserted-by":"publisher","first-page":"e105119","DOI":"10.1371\/journal.pone.0105119","volume":"9","author":"BM Weltermann","year":"2014","unstructured":"Weltermann\u00a0BM, Markic\u00a0M, Thielmann\u00a0A et\u00a0al (2014) Vaccination management and vaccination errors: a\u00a0representative online-survey among primary care physicians. Plos One 9(8):e105119","journal-title":"Plos One"},{"key":"1857_CR19","unstructured":"World Health Organisation (2024) COVID-19-Impfungen haben \u00fcber 1,4\u00a0Mio. Menschenleben in der Europ\u00e4ischen Region der WHO gerettet, stellt eine neue Studie fest (16.01.2024). https:\/\/www.who.int\/europe\/de\/emergencies\/overview\/16-01-2024-covid-19-vaccinations-have-saved-more-than-1.4-million-lives-in-the-who-european-region--a-new-study-finds. Zugegriffen: 23. Sept. 2024"}],"container-title":["Die Innere Medizin"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-01857-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00108-025-01857-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-025-01857-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T14:24:55Z","timestamp":1741184695000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00108-025-01857-w"}},"subtitle":["Indikationsimpfungen bei Erwachsenen","Indication vaccinations for adults"],"short-title":[],"issued":{"date-parts":[[2025,2,11]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["1857"],"URL":"https:\/\/doi.org\/10.1007\/s00108-025-01857-w","relation":{},"ISSN":["2731-7080","2731-7099"],"issn-type":[{"type":"print","value":"2731-7080"},{"type":"electronic","value":"2731-7099"}],"subject":[],"published":{"date-parts":[[2025,2,11]]},"assertion":[{"value":"21 January 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 February 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"J.\u00a0Floege: Honorare f\u00fcr Beratungen und Vortr\u00e4ge von AstraZeneca, Bayer, Boehringer Ingelheim, CSL Vifor, GSK, Lilly, Novartis, Novo Nordisk, Roche, und Stadapharm T.\u00a0Schwarz: Honorare f\u00fcr Beratungen, Vortr\u00e4ge und klinische Studien von Abbott, Astra Zeneca, Bayer, Boehringer Ingelheim, DDG, Daiichi-Sankyo, diateam, Eli Lilly, Esperion, Gr\u00fcnenthal, GSK, IQVIA, med-info GmbH, NewAmsterdam, Novo Nordisk, Parexel, Sanofi-Aventis, Santis, Vertanical; TS ist Vorsitzender des BVND (Bundesverband der Niedergelassenen Diabetologen), Vorstandsmitglied des BVNDS (Berufsverband niedergelassener Diabetologen in Sachsen) und des Hartmannbundes, LV Sachsen.. C.\u00a0Wanner: Honorare f\u00fcr Steuerungskomitees, Beratungen und Vortr\u00e4ge von AMGEN, AstraZeneca, Bayer, Boehringer Ingelheim, CSL-Vifor, Eli-Lilly, GSK, Novartis, Novo Nordisk und Sanofi. U.\u00a0Heemann: Honorare f\u00fcr Beratungen und Vortr\u00e4ge von GSK. B.\u00a0Gallwitz: Honorare f\u00fcr Beratungen und Vortr\u00e4ge von AstraZeneca, Bayer, Boehringer Ingelheim, Bristol Myers Squibb, Fractyl, GSK, Lilly und Novo Nordisk. O.\u00a0Witzke: Honorare f\u00fcr Beratungen, Vortr\u00e4ge und klinische Studien von Amgen, Alexion, Astellas, Astra Zeneca, Basilea, Biotest, Bristol-Myers Squibb, Correvio, Chiesi, Gilead, GSK, Hexal, Janssen, Dr. F. K\u00f6hler Chemie, Moderna, MSD, Novartis, Roche, Pfizer, Sanofi, Shionogi, Takeda, TEVA, Tillotts und UCB.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}